NAVBO Workshops at Vascular Biology 2019

血管生物学2019 NAVBO的发育血管生物学和遗传学研讨会 （主办方：维多利亚鲍奇，北卡罗来纳大学教堂山和考特尼格里芬，OMRF） 和 NAVBO的血管基质生物学和生物工程研讨会 （组织者：德克萨斯A&M大学的Kayla Bayless和斯坦福大学的Marlene Rabinovitch） 2019年10月27日至31日 阿西洛马会议场地，太平洋格罗夫，加州 主要研究者：维多利亚鲍奇 项目总结/摘要 近年来，血管生物学领域经历了信息爆炸。鉴于此 随着信息的日益丰富，越来越需要进行跨学科的思想交流和讨论。 血管生物学在过去的十年中已经发展成为一个主要的交叉学科领域，影响了许多领域。 主要的人类疾病，包括动脉粥样硬化、高血压、肺病、癌症、神经系统疾病， 糖尿病、中风和血液病。导致这些病理的许多关键细胞事件 在维管发育过程中发生的过程，并受到遗传、维管 细胞反应、细胞外基质和生物物理力。这个重要的交叉点， 发育生物学、遗传学、基质生物学和生物工程学对血管生成具有重要意义。 疾病，包括那些起源于微循环的疾病，以及干细胞生物学，血管 分化和再生。第八届发育血管生物学和遗传学研讨会将于 与第七届血管基质生物学和生物工程研讨会同时举行， 来自微循环协会这次联席会议将汇集具有以下共同兴趣的科学家， 了解血管在发育过程中如何形成，这些信息如何与病理状态相关， 以及如何利用它进行再生。该计划的发展，包括最新的未公布的 在这些领域和微循环领域感兴趣的主题信息，并整合新的， 在每个领域和这些以前独立的领域的交叉点出现新的主题。 我们要求提供资金，以部分支持跨学科的国际讲习班，这些讲习班还将 结合微循环的各个方面，并汇集来自学术和私人的研究人员， 与会者沿着来自不同领域的学员进行了为期五天的紧张讨论和学习。的 会议将于2019年10月27日至31日在加利福尼亚州太平洋格罗夫的Asilomar会议场地举行。我们 我有一个发言人名单，其中包括发育血管生物学和遗传学，血管 基质生物学和生物工程学，以及微循环。我们还邀请了一些资历较浅的演讲者， 在血管研究方面取得突破的研究人员。此外，几乎一半的研讨会发言人将 从提交的摘要中选择，以捕捉这些学科中最新的未发表的工作， 大多数来自早期研究者和学员的抽象演示。我们的目标是培养高水平的 在不同的研究者群体中交流思想，包括那些直接参与翻译的人。 research.我们包括新兴技术和血管治疗学的联合会议，以促进 参与基础和临床/转化研究的研究人员之间的互动。会议寻求洞察力 新的治疗方法，以改善广泛的病理状态，包括 发育缺陷、动脉粥样硬化、高血压、心肌梗死和中风。

Vascular Biology 2019 NAVBO's Developmental Vascular Biology and Genetics Workshop (Organizers: Victoria Bautch, UNC-Chapel Hill and Courtney Griffin, OMRF) and NAVBO's Vascular Matrix Biology and Bioengineering Workshop (Organizers: Kayla Bayless, Texas A&M University and Marlene Rabinovitch, Stanford University) October 27-31, 2019 Asilomar Conference Grounds, Pacific Grove, California Principal Investigator: Victoria Bautch Project Summary/Abstract The field of vascular biology has experienced an explosion of information in recent years. In light of this wealth of information, there is an increased need for interdisciplinary exchange of ideas and discussion. Vascular biology has evolved over the past decade as a major cross-disciplinary field that impacts numerous major human diseases, including atherosclerosis, hypertension, lung disease, cancer, neurological disorders, diabetes, stroke, and hematological disorders. Many key cellular events leading to these pathologies recapitulate processes that take place during vascular development and are influenced by genetics, vascular cell responses, the extracellular matrix, and biophysical forces. This important intersection between developmental biology, genetics, matrix biology, and bioengineering has major implications for vascular diseases, including those that originate in the microcirculation, and also for stem cell biology, vascular differentiation, and regeneration. The eighth Developmental Vascular Biology and Genetics Workshop will be held concurrently with the seventh Vascular Matrix Biology and Bioengineering Workshop, with contributions from the Microcirculatory Society. This joint meeting will bring together scientists with the common interest of understanding how blood vessels form in development, how this information pertains to pathological states, and how it can be exploited for regeneration. The program was developed to include the latest unpublished information in topics of interest in both of these fields and the microcirculation field, and to integrate novel, emerging themes in each area and at the intersection of these previously separate fields. We request funds to partially support both interdisciplinary, international workshops, which will also incorporate aspects of the microcirculation and bring together investigators from the academic and private sectors, along with trainees from diverse fields of study for five days of intense discussion and study. The meeting will be held at the Asilomar Conference Grounds in Pacific Grove, CA from October 27-31, 2019. We have a roster of speakers that includes leaders in developmental vascular biology and genetics, vascular matrix biology and bioengineering, and microcirculation. We also include among invited speakers more junior investigators making breakthroughs in vascular research. In addition, almost half of the workshop speakers will be chosen from submitted abstracts to capture the latest unpublished work in these disciplines, with the majority of abstract presentations from early stage investigators and trainees. Our goal is to foster high-level exchange of ideas amongst a diverse group of investigators, including those directly involved in translational research. We include joint sessions on emerging technologies and vascular therapeutics to facilitate interactions among researchers involved in basic and clinical/translational research. The meeting seeks insight into new therapeutic approaches to ameliorate a broad spectrum of pathological states, including developmental defects, atherosclerosis, hypertension, myocardial infarction, and stroke.